GFM
TECH icon

GF Fund Management’s Bio-Techne TECH Stock Holding History

GF Fund Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
4,258
+45
+1% +$2.43K ﹤0.01% 243
2026
Q1 		$220K Hold
4,213
– – ﹤0.01% 278
2025
Q4 		$248K Sell
4,213
-78
-2% -$4.74K ﹤0.01% 276
2025
Q3 		$239K Buy
4,291
+391
+10% +$20.9K ﹤0.01% 273
2025
Q2 		$201K Sell
3,900
-29
-0.7% -$1.46K ﹤0.01% 318
2025
Q1 		$230K Hold
3,929
– – 0.01% 312
2024
Q4 		$283K Buy
+3,929
New +$289K 0.01% 261

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GF Fund Management's TECH Position: Q2 2026 in Review

GF Fund Management increased its Bio-Techne (TECH) stake by 1.1% in Q2 2026, buying an estimated $2.43K and bringing the position to 4,258 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #243.

GF Fund Management first reported a position in TECH in Q4 2024 and has held it in 7 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • GF Fund Management held 4,258 shares of Bio-Techne worth $301K as of Q2 2026.
  • GF Fund Management bought 45 Bio-Techne shares in Q2 2026, an estimated $2.43K.
  • Bio-Techne made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #243 holding.
  • GF Fund Management first reported a position in Bio-Techne in Q4 2024 and has held it in 7 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.